Tami de Araujo, MD; Isabel Valencia, MD; Daniel G. Federman, MD; Robert S. Kirsner, MD
Requests for Single Reprints: Robert S. Kirsner, MD, Department of Dermatology, University of Miami, Veterans Administration Medical Center, 1201 NW 16th Street, Miami, FL 33125; e-mail, Rkirsner@med.miami.edu.
Current Author Addresses: Drs. de Araujo, Valencia, and Kirsner: University of Miami School of Medicine, 1201 NW 16th Street, Miami, FL 33125.
Dr. Federman: Yale University School of Medicine, Veterans Administration Connecticut Health Care System (11ACSL), 950 Campbell Avenue, West Haven, CT 06516.
Venous disease is the most common cause of leg ulcers. The refractory nature of venous ulcers affects the quality of life and work productivity of those persons afflicted. This, in combination with the high costs of long-term therapy, makes venous ulcers a major health problem in developed countries. Management of venous leg ulcers is based on understanding pathophysiologic abnormalities. In recent years, identifying prognostic factors for healing and developing novel therapeutic approaches for venous ulcers have offered valuable tools for the management of patients with this disorder.
de Araujo T, Valencia I, Federman DG, et al. Managing the Patient with Venous Ulcers. Ann Intern Med. 2003;138:326–334. doi: https://doi.org/10.7326/0003-4819-138-4-200302180-00012
Download citation file:
Published: Ann Intern Med. 2003;138(4):326-334.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use